The Vanderbilt community is invited to attend the 12th annual Research Retreat, a showcase of cutting-edge biomedical science by Vanderbilt faculty members and trainees.

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer.

Michael Merzenich, Ph.D., author of “Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life,” will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Sept. 26, in 208 Light Hall.

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism.

Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall.